SG11201403712XA - Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life - Google Patents

Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life

Info

Publication number
SG11201403712XA
SG11201403712XA SG11201403712XA SG11201403712XA SG11201403712XA SG 11201403712X A SG11201403712X A SG 11201403712XA SG 11201403712X A SG11201403712X A SG 11201403712XA SG 11201403712X A SG11201403712X A SG 11201403712XA SG 11201403712X A SG11201403712X A SG 11201403712XA
Authority
SG
Singapore
Prior art keywords
carotenoids
life
infant formula
health effects
formula containing
Prior art date
Application number
SG11201403712XA
Inventor
Barbara J Marriage
Christine L Gallardo
Christina Sherry
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SG11201403712XA publication Critical patent/SG11201403712XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11201403712XA 2011-12-27 2012-12-04 Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life SG11201403712XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161580442P 2011-12-27 2011-12-27
PCT/US2012/067712 WO2013180747A2 (en) 2011-12-27 2012-12-04 Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life

Publications (1)

Publication Number Publication Date
SG11201403712XA true SG11201403712XA (en) 2014-10-30

Family

ID=49170844

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201403712XA SG11201403712XA (en) 2011-12-27 2012-12-04 Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life

Country Status (12)

Country Link
US (1) US9474766B2 (en)
EP (1) EP2797432A2 (en)
CN (1) CN104114043B (en)
BR (1) BR112014016135A8 (en)
CA (1) CA2861547A1 (en)
HK (1) HK1203038A1 (en)
IL (1) IL233298A0 (en)
MX (1) MX2014007936A (en)
PH (1) PH12014501493A1 (en)
SG (1) SG11201403712XA (en)
TW (1) TWI472300B (en)
WO (1) WO2013180747A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2797432A2 (en) 2011-12-27 2014-11-05 Abbott Laboratories Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
CN115227706B (en) * 2022-06-08 2023-12-29 陈玉松 Application of nucleotide 5' -monophosphate composition in preparation of fat-reducing and weight-losing functional foods and medicines

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5031156B2 (en) 2001-09-20 2012-09-19 カゴメ株式会社 Anti-obesity agent
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
EP1656839A1 (en) * 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
DK1800675T3 (en) 2005-12-23 2011-09-05 Nutricia Nv Compositions comprising polyunsaturated fatty acids, proteins and manganese and / or molybdenum and nucleosides / nucleotides for the treatment of dementia
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
US20090118227A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
PL2234505T3 (en) 2007-12-21 2013-06-28 Nutricia Nv Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota
RU2010143460A (en) * 2008-05-01 2012-06-10 Дзе Проктер Энд Гэмбл Компани (US) METHODS AND KITS FOR THERAPY OF REDUCING INTESTINAL STATES
MX2011010229A (en) * 2009-04-01 2011-10-11 Nestec Sa Reduction of risk of obesity.
TW201121431A (en) 2009-12-01 2011-07-01 Abbott Lab Soy protein-based nutritional formula with superior stability
EP2797432A2 (en) 2011-12-27 2014-11-05 Abbott Laboratories Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life

Also Published As

Publication number Publication date
IL233298A0 (en) 2014-08-31
TWI472300B (en) 2015-02-11
MX2014007936A (en) 2014-07-30
TW201328610A (en) 2013-07-16
BR112014016135A2 (en) 2017-06-13
CN104114043A (en) 2014-10-22
US9474766B2 (en) 2016-10-25
NZ626947A (en) 2016-01-29
WO2013180747A3 (en) 2014-03-06
HK1203038A1 (en) 2015-10-16
CN104114043B (en) 2016-10-19
WO2013180747A2 (en) 2013-12-05
US20150011498A1 (en) 2015-01-08
CA2861547A1 (en) 2013-12-05
BR112014016135A8 (en) 2017-07-04
EP2797432A2 (en) 2014-11-05
PH12014501493A1 (en) 2014-09-22

Similar Documents

Publication Publication Date Title
ZA201403591B (en) Composition for use in brain growth and/or cognitive and/or psychomotor developmen
IL232256A0 (en) Novel purine derivatives and their use in the treatment of disease
PL3167726T3 (en) Modulation of post-prandial fat absorption
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
AU339607S (en) Medical device for treatment of sleep disorders
EP2680808A4 (en) Pacifier for use with premature newborns and infants
ZA201301234B (en) Methods of reducing blood lactate concentration
IL228771A0 (en) Glycoside derivatives and their uses for the treatment of diabetes
IL228419A0 (en) Infant formula for use in the prevention of cardiovascular diseases
IL231483A0 (en) An efficient process for the prepsration of lycopene containing oleoresin and lycopene crystals for human consumption
EP2740728A4 (en) Uracil derivative and use thereof for medical purposes
IL229381B (en) Brilacidin and derivatives thereof for use in treatment of mucositis
HRP20170248T1 (en) Aclidinium for use in improving the quality of sleep in respiratory patients
HK1196535A1 (en) Salt and medical use
EP2709999A4 (en) Quinazoline-7-ether compounds and methods of use
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
HK1203038A1 (en) Use of reduced calorie infant formula containing nucleotides and or carotenoids for reducing adverse health effects later in life
IN2014MN02263A (en)
HK1202819A1 (en) Treatment of type i and type ii diabetes i ii
PL2709584T3 (en) Sensory use of 6-cyclopentylidenehexane derivatives
IL227580A0 (en) Use of hgh for the treatment of small for gestational age infants under two years of age
GB201119458D0 (en) Compositions for treatment of sleep disorders
GB201118452D0 (en) The use of increased oxygen concentrations in soft drinks
HK1155318A2 (en) Jade pillow for health care